(AKAN) Akanda - Performance -68.6% in 12m
AKAN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-75.67%
#116 in Peer-Group
Rel. Strength
5.04%
#7277 in Stock-Universe
Total Return 12m
-68.58%
#159 in Peer-Group
Total Return 5y
-99.98%
#198 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.62 USD |
| 52 Week Low | 1.07 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 83.17 |
| Buy/Sell Signal +-5 | -0.99 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AKAN (-68.6%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: AKAN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AKAN
| Total Return (including Dividends) | AKAN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.74% | 3.15% | 4.01% |
| 3 Months | 24.55% | 17.08% | 17.14% |
| 12 Months | -68.58% | -11.14% | 13.46% |
| 5 Years | -99.98% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | AKAN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 40.2% | 52.1% | 90.3% |
| 3 Months | 80.4% | 79.4% | 97.5% |
| 12 Months | -86.1% | -87.4% | 46.4% |
| 5 Years | -99.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th52.50 | -2.34% | -3.15% |
| 3 Month | %th57.00 | 6.37% | 6.32% |
| 12 Month | %th21.50 | -64.64% | -72.31% |
| 5 Years | %th0.50 | -99.98% | -99.99% |
FAQs
Does Akanda (AKAN) outperform the market?
No,
over the last 12 months AKAN made -68.58%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months AKAN made 24.55%, while XBI made 17.08%.
Performance Comparison AKAN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AKAN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.6% | -3.3% | -23.9% | -82% |
| US NASDAQ 100 | QQQ | 6.6% | -3.5% | -25.9% | -82% |
| German DAX 40 | DAX | 6.2% | -0.5% | -36% | -99% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.4% | -3.8% | -28.3% | -87% |
| Hongkong Hang Seng | HSI | 5.7% | -2.1% | -45.9% | -104% |
| India NIFTY 50 | INDA | 7.9% | 1.6% | -24.3% | -66% |
| Brasil Bovespa | EWZ | 10.8% | 1.4% | -38.9% | -70% |
AKAN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8% | -1% | -27.2% | -92% |
| Consumer Discretionary | XLY | 5.6% | -2.6% | -16.2% | -87% |
| Consumer Staples | XLP | 8.6% | 0.9% | -22.9% | -76% |
| Energy | XLE | 3.6% | -3.4% | -16.3% | -71% |
| Financial | XLF | 8% | -1.9% | -26.2% | -94% |
| Health Care | XLV | 6.4% | 0.7% | -12.4% | -62% |
| Industrial | XLI | 6.2% | -3.7% | -29.7% | -92% |
| Materials | XLB | 5.9% | -3.7% | -24.5% | -73% |
| Real Estate | XLRE | 6.8% | 0.9% | -22.3% | -77% |
| Technology | XLK | 6.7% | -5.9% | -29% | -80% |
| Utilities | XLU | 6.5% | -1.9% | -27.9% | -89% |
| Aerospace & Defense | XAR | 5.9% | -6.1% | -43.8% | -118% |
| Biotech | XBI | 2.9% | -2.4% | -13.6% | -57% |
| Homebuilder | XHB | 3.5% | -8% | -17.3% | -67% |
| Retail | XRT | 6.6% | -2.5% | -19% | -75% |
AKAN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6% | -2.56% | -9.94% | -64% |
| Natural Gas | UNG | 8.3% | 7.2% | 2.2% | -67% |
| Gold | GLD | 6.5% | 0.5% | -41.8% | -107% |
| Silver | SLV | 2.2% | -5.6% | -45.9% | -91% |
| Copper | CPER | -3.8% | -14.2% | -43.4% | -92% |
AKAN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.4% | 0.8% | -18.5% | -64% |
| iShares High Yield Corp. Bond | HYG | 7.1% | -0.4% | -20.9% | -78% |